PX-12 induces apoptosis in Calu-6 cells in an oxidative stress-dependent manner

Tumor Biology

Volumn 36, Issue 3, 2015, Pages 2087-2095

  You, Bo Ra ^a   Shin, Hye Rim ^a   Han, Bo Ram ^a   Park, Woo Hyun ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Apoptosis; Lung cancer; PX 12; Reactive oxygen species; Thioredoxin

Indexed keywords

ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; DISULFIDE; FITC-ANNEXIN A5; FLUORESCEIN ISOTHIOCYANATE; GLUTATHIONE; IMIDAZOLE DERIVATIVE; IV 2 COMPOUND; LIPOCORTIN 5; REACTIVE OXYGEN METABOLITE;

ANALOGS AND DERIVATIVES; APOPTOSIS; CELL DEATH; DRUG EFFECTS; EPITHELIUM CELL; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; M PHASE CELL CYCLE CHECKPOINT; METABOLISM; OXIDATIVE STRESS; TUMOR CELL LINE;

ACETYLCYSTEINE; ANNEXIN A5; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CELL DEATH; CELL LINE, TUMOR; DISULFIDES; EPITHELIAL CELLS; FLUORESCEIN-5-ISOTHIOCYANATE; G2 PHASE CELL CYCLE CHECKPOINTS; GLUTATHIONE; HUMANS; IMIDAZOLES; M PHASE CELL CYCLE CHECKPOINTS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84930915156     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2816-x     Document Type: Article

References (38)

1. Shi Y, Tang B, Yu PW, Hao YX, Lei X, Luo HX, et al. Autophagy protects against oxaliplatin-induced cell death via ER stress and ROS in Caco-2 cells. PLoS One. 2012;7:e51076.
2. Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta. 2006;1757:509–17.
3. Gonzalez C, Sanz-Alfayate G, Agapito MT, Gomez-Nino A, Rocher A, Obeso A. Significance of ROS in oxygen sensing in cell systems with sensitivity to physiological hypoxia. Respir Phys Neurobiol. 2002;132:17–41.
4. Baran CP, Zeigler MM, Tridandapani S, Marsh CB. The role of ROS and RNS in regulating life and death of blood monocytes. Curr Pharm Des. 2004;10:855–66.
5. Lo YL, Wang W, Ho CT. 7,3′,4′-trihydroxyisoflavone modulates multidrug resistance transporters and induces apoptosis via production of reactive oxygen species. Toxicology. 2012;302:221–32.
6. Bell EL, Emerling BM, Ricoult SJ, Guarente L. SirT3 suppresses hypoxia inducible factor 1alpha and tumor growth by inhibiting mitochondrial ROS production. Oncogene. 2011;30:2986–96.
7. Li C, Thompson MA, Tamayo AT, Zuo Z, Lee J, Vega F, et al. Over-expression of thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large b-cell lymphoma. Oncotarget. 2012;3:314–26.
8. Yang J, Li C, Ding L, Guo Q, You Q, Jin S. Gambogic acid deactivates cytosolic and mitochondrial thioredoxins by covalent binding to the functional domain. J Nat Prod. 2012;75:1108–16.
9. Chae JS, Gil Hwang S, Lim DS, Choi EJ. Thioredoxin-1 functions as a molecular switch regulating the oxidative stress-induced activation of MST1. Free Radic Biol Med. 2012;53:2335–43.
10. Ungerstedt J, Du Y, Zhang H, Nair D, Holmgren A. In vivo redox state of human thioredoxin and redox shift by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA). Free Radic Biol Med. 2012;53:2002–7.
11. Lim JY, Yoon SO, Hong SW, Kim JW, Choi SH, Cho JY. Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence. World J Gastroenterol: WJG. 2012;18:5581–8.
12. Pramanik KC, Srivastava SK. Apoptosis signal-regulating kinase 1-thioredoxin complex dissociation by capsaicin causes pancreatic tumor growth suppression by inducing apoptosis. Antioxid Redox Signal. 2012;17:1417–32.
13. Dunn LL, Buckle AM, Cooke JP, Ng MK. The emerging role of the thioredoxin system in angiogenesis. Arterioscler Thromb Vasc Biol. 2010;30:2089–98.
14. Cha MK, Suh KH, Kim IH. Overexpression of peroxiredoxin i and thioredoxin1 in human breast carcinoma. J Exp Clin Cancer Res: CR. 2009;28:93.
15. Wondrak GT. Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal. 2009;11:3013–69.
16. Welsh SJ, Williams RR, Birmingham A, Newman DJ, Kirkpatrick DL, Powis G. The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation. Mol Cancer Ther. 2003;2:235–43.
17. Mukherjee A, Martin SG. The thioredoxin system: a key target in tumour and endothelial cells. Br J Radiol. 2008;81(Spec No 1):S57–68.
18. Baker AF, Adab KN, Raghunand N, Chow HH, Stratton SP, Squire SW, Boice M, Pestano LA, Kirkpatrick DL, Dragovich T. A phase ib trial of 24-hour intravenous px-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers. Investig New Drugs. 2012.
19. Ramanathan RK, Kirkpatrick DL, Belani CP, Friedland D, Green SB, Chow HH, et al. A phase i pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors. Clin Cancer Res: Off J Am Assoc Cancer Res. 2007;13:2109–14.
20. Petty RD, Nicolson MC, Kerr KM, Collie-Duguid E, Murray GI. Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Clin Cancer Res: Off J Am Assoc Cancer Res. 2004;10:3237–48.
21. Fernandes AP, Capitanio A, Selenius M, Brodin O, Rundlof AK, Bjornstedt M. Expression profiles of thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differentiation. Histopathology. 2009;55:313–20.
22. Wangpaichitr M, Sullivan EJ, Theodoropoulos G, Wu C, You M, Feun LG, et al. The relationship of thioredoxin-1 and cisplatin resistance: its impact on ros and oxidative metabolism in lung cancer cells. Mol Cancer Ther. 2012;11:604–15.
23. Han YH, Kim SZ, Kim SH, Park WH. Pyrogallol inhibits the growth of lung cancer calu-6 cells via caspase-dependent apoptosis. Chem Biol Interact. 2009;177:107–14.
24. Han YH, Park WH. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin a-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione. Oncol Rep. 2009;22:385–91.
25. Han YH, Moon HJ, You BR, Kim SZ, Kim SH, Park WH. Effects of carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone on the growth inhibition in human pulmonary adenocarcinoma Calu-6 cells. Toxicology. 2009;265:101–7.
26. You BR, Park WH. Zebularine inhibits the growth of hela cervical cancer cells via cell cycle arrest and caspase-dependent apoptosis. Mol Biol Rep. 2012;39:9723–31.
27. Harlow E, Lane D: Bradford assay. CSH Protoc. 2006;2006.
28. Han YH, Moon HJ, You BR, Park WH. The effect of mg132, a proteasome inhibitor on hela cells in relation to cell growth, reactive oxygen species and gsh. Oncol Rep. 2009;22:215–21.
29. Han YH, Kim SH, Kim SZ, Park WH. Carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (fccp) as an O2(*-) generator induces apoptosis via the depletion of intracellular GSH contents in Calu-6 cells. Lung Cancer. 2009;63:201–9.
30. Han YH, Park WH. Propyl gallate inhibits the growth of hela cells via regulating intracellular GSH level. Food Chem Toxicol: Int J Publ Br Ind Biol Res Assoc. 2009;47:2531–8.
31. You BR, Park WH. Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase. Toxicol In Vitro: Int J Publ Assoc BIBRA. 2010;24:1356–62.
32. Griffiths EJ. Mitochondria—potential role in cell life and death. Cardiovasc Res. 2000;46:24–7.
33. Testa B, Kramer SD. The biochemistry of drug metabolism—an introduction: Part 4. Reactions of conjugation and their enzymes. Chem Biodivers. 2008;5:2171–336.
34. Vogt A, Tamura K, Watson S, Lazo JS. Antitumor imidazolyl disulfide IV-2 causes irreversible G(2)/M cell cycle arrest without hyperphosphorylation of cyclin-dependent kinase Cdk1. J Pharmacol Exp Ther. 2000;294:1070–5.
35. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997;275:1129–32.
36. Lee YJ, Kim JH, Chen J, Song JJ. Enhancement of metabolic oxidative stress-induced cytotoxicity by the thioredoxin inhibitor 1-methylpropyl 2-imidazolyl disulfide is mediated through the ASK1-SEK1-JNK1 pathway. Mol Pharmacol. 2002;62:1409–17.
37. Estrela JM, Ortega A, Obrador E. Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci. 2006;43:143–81.
38. You BR, Park WH. Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ros levels and GSH depletion. Oncol Rep. 2012;28:749–57.